Effects of SLCO1B1 polymorphisms on plasma estrogen concentrations in women with breast cancer receiving aromatase inhibitors exemestane and letrozole

Jacqueline M. Dempsey, Kelley M. Kidwell, Christina L. Gersch, Andrea M. Pesch, Zeruesenay Desta, Anna Maria Storniolo, Vered Stearns, Todd C. Skaar, Daniel F. Hayes, N. Lynn Henry, James M. Rae, Daniel L. Hertz

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Effects of SLCO1B1 polymorphisms on plasma estrogen concentrations in women with breast cancer receiving aromatase inhibitors exemestane and letrozole'. Together they form a unique fingerprint.

Medicine & Life Sciences